scholarly journals Idiopathic Intracranial Hypertension: Neuropsychiatric Systemic Lupus Erythematosus or Gonadotropinreleasing hormone agonist side effect?

2017 ◽  
Vol 1 (1) ◽  
pp. 023-024
Author(s):  
OP Seung ◽  
NY Muh ◽  
KC Gek
Lupus ◽  
2009 ◽  
Vol 18 (12) ◽  
pp. 1121-1123 ◽  
Author(s):  
R Barahona-Hernando ◽  
JJ Ríos-Blanco ◽  
I Méndez-Mesón ◽  
I Pérez-Valero ◽  
CI Soto-Abánades ◽  
...  

2018 ◽  
Vol 7 (2) ◽  
pp. 40-42
Author(s):  
Bhupendra Shah ◽  
Mathew Ibrahim Amprayil ◽  
Rahul Taparia ◽  
Shailesh Mani Pokhrel

Correction: Unfortunately, several authors on this paper were omitted. Therefore, on 15th April 2019 the following authors were added to the paper: Mathew Ibrahim Amprayil, Rahul Taparia and Shailesh Mani Pokhrel. The editorial board apologises for this error. The common risk factors for Idiopathic intracranial hypertension are obesity, female gender, hypervitaminosis A, and steroid withdrawal. Even though Idiopathic intracranial hypertension is considered as a neuropsychiatric manifestation of Systemic lupus erythematosus, it is often missed by the physician as a cause of a headache in a patient with Systemic lupus erythematosus. We report a case of 21-year-old female who presented in our outpatient department with a history of a severe intractable progressive headache for a duration of four weeks and blurring of vision for five days who was later diagnosed as a case of idiopathic intracranial hypertension with Systemic lupus erythematosus. She recovered dramatically with the institution of steroid and acetazolamide therapy.


2011 ◽  
Vol 26 (12) ◽  
pp. 1576-1579 ◽  
Author(s):  
Constantine D. Georgakopoulos ◽  
Odysseas Kargiotis ◽  
Maria I. Eliopoulou ◽  
Olga E. Makri ◽  
Artemis M. Exarchou ◽  
...  

We present the case of a 14-year-old girl who was admitted to the hospital with the complaint of horizontal diplopia for 48 hours. Initially, she was diagnosed with idiopathic intracranial hypertension. During hospitalization she developed fever, macular facial rash, and chest pain, and because of abnormal laboratory findings the diagnosis of systemic lupus erythematosus was established. She received immunomodulatory therapy, a combination of corticosteroids, and intravenous infusions of the monoclonal antibody rituximab, which augmented her clinical improvement. Intracranial hypertension secondary to systemic lupus erythematosus is a rare manifestation, especially as a presenting symptom. In addition, the fact that the patient developed an aggressive form of systemic lupus erythematosus during the initial period of hospitalization for idiopathic intracranial hypertension is also uncommon. Moreover, to our knowledge, we are not aware of any published case reports of intracranial hypertension secondary to systemic lupus erythematosus that was treated with rituximab.


2013 ◽  
Vol 2013 (jan31 1) ◽  
pp. bcr2012007886-bcr2012007886 ◽  
Author(s):  
C. Rajasekharan ◽  
S. W. Renjith ◽  
A. Marzook ◽  
R. Parvathy

Sign in / Sign up

Export Citation Format

Share Document